Phase II Open Label Comparative Study of Cetuximab and Radiation Therapy Vs Surgery Before or After Radiation Therapy in Patients With Stage II to IV Colorectal Carcinoma.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CC-ASI
- 03 Feb 2010 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 18 Nov 2009 Planned end date changed from 1 Dec 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.